Anatomy and Pathophysiology of the Prostate Gland

  • R. S. Kirby


The origin of the term “prostate” was originally derived from the Greek prohistani (to stand in front of) and has been attributed to Herophilus of Alexandria, who used the expression in 335 B.C. to describe the organ located “in front of” the urinary bladder. However, while the existence of the prostate has been recognised for over 2300 years, the gland’s anatomy, physiology and pathology has been described in detail only within the past six decades. Recently there has been a flurry of interest and activity in relation to the three major prostatic diseases: benign prostatic hyperplasia (BPH), carcinoma of the prostate and prostatitis. This is partly because demographic changes have led to an ever-increasing proportion of men attaining an age at which they are especially susceptible to these disorders, and because of the introduction of new therapies for these diseases. Central to the understanding of both benign and malignant prostatic pathology is comprehension of the zonal anatomy. This chapter relates differences in zonal anatomy to the various pathological processes which frequently affect this gland.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ayala AG, Ro JY, Babian R, Troncoso P, Grignon DJ (1989) The prostatic capsule: does it exist? Am J Surg Pathol 13:21PubMedCrossRefGoogle Scholar
  2. Bostnick DG (1987) Introductal dysplasia: a premaliquand condition of the prostate. Hum Pathol 17:64–71Google Scholar
  3. Bostwick DG, Brawer MK (1987) Prostatic intraepithelial neoplasia and early invasion in prostate cancer. Cancer 59:788–794PubMedCrossRefGoogle Scholar
  4. Drach GW, Layton TN, Binard WJ (1979) Male peak urinary flow rate: relationship of volume voided and age. J Urol 122:210–214PubMedGoogle Scholar
  5. Dube VE, Farrow GM, Greene LF (1973) Prostatic adenocarcinoma of ductal origin. Cancer 32:402–409PubMedCrossRefGoogle Scholar
  6. Efros MD, Fischer J, Mallouh C, Choudhury M, Georgsson S (1992) Unusual primary prostatic malignancies. Urology 39:407–410PubMedCrossRefGoogle Scholar
  7. Elbadawi A, Craig W, Linke CA, Cooper RA Jr (1979) Prostatic mucinous carcinoma. Urology 13:658–666PubMedCrossRefGoogle Scholar
  8. Epstein JI, Lieberman PH (1985) Mucinous adenocarcinoma of the prostate gland. Am J Surg Pathol 9:299–308PubMedCrossRefGoogle Scholar
  9. Epstein JI, Cho KR, Quinn BD (1990) Relationship of severe dysplasia to stage A (incidental) adenocarcinoma of the prostate. Cancer 65:2321–2327PubMedCrossRefGoogle Scholar
  10. Gleason DF (1977) Histologic grading and clinical staging of prostatic carcinoma. In: Tannenbaum M (ed) Urologic pathology: the prostate. Lea and Febiger, Philadelphia, pp 171–198Google Scholar
  11. Gleason DF (1992) Histologic grading of prostate cancer: a perspective. Hum Pathol 23:273–279PubMedCrossRefGoogle Scholar
  12. Greene LF, Farrow GM, Ravits JM, Tomera FM (1979) Prostatic adenocarcinoma of duct origin. J Urol 121:303–305PubMedGoogle Scholar
  13. Humphrey PA (1991) Mutin in severe dysplasia in the prostate. Surg Pathol 4:137–143Google Scholar
  14. Kopelson G, Harisiadis L, Romos NA, Veenema RJ, Tannenbaum M (1978) Periurethral prostatic duct carcinoma: clinical features and treatment results. Cancer 42:2894–2902PubMedCrossRefGoogle Scholar
  15. Lemberger RJ, Bishop MC, Bates CP, Blundell W, Ansell ID (1984) Carcinoma of the prostate of ductal origin. Br J Urol 56:706–709PubMedCrossRefGoogle Scholar
  16. Lowsley OS (1912) The development of the human prostate gland with reference to the development of other structures of the neck of the urinary bladder. Am J Anat 13:299CrossRefGoogle Scholar
  17. McNeal JE (1968) Regional morphology and pathology of the prostate. Am J Clin Pathol 49:347–357PubMedGoogle Scholar
  18. McNeal JE (1988) Normal histology of the prostate. Am J Surg Pathol 12:619–633PubMedCrossRefGoogle Scholar
  19. McNeal JE (1992) Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread. Hum Pathol 23:258–266PubMedCrossRefGoogle Scholar
  20. McNeal JE, Alroy J, Leau I, Redwine EA, Freiha FS, Stamey TA (1988) Immunohistochemical evidence for impaired cell differentiation in the premalignant phase of prostate carcinogenesis. Am J Clin Pathol 90:23–32PubMedGoogle Scholar
  21. Melicow MM, Pachter MR (1967) Endometrial carcinoma of prostatic utricle (uterus masculinus). Cancer 20:1715–1722PubMedCrossRefGoogle Scholar
  22. Miller GJ (1988) An atlas of prostatic biopsies: dilemmas of morphologic variance. In: Fenoglio-Preiser CM, Wolff M, Rilke F (eds) Progress in surgical pathology VIII. Field and Wood, Philadelphia, pp 81–112Google Scholar
  23. Miller GJ (1990) New developments in grading prostate cancer. Semin Urol 8:9–18PubMedGoogle Scholar
  24. Nadji M, Tabei SZ, Castro A, Chu TM, Morales AR (1980) Prostatic origin of tumours: an immunohistochemical study. Am J Clin Pathol 73:735–739PubMedGoogle Scholar
  25. Nagle RB, Brewer MK, Kittelson J, Clark V (1991) Phenotypic relationship of prostatic intraepithelial neoplasia to invasive prostatic carcinoma. Am J Pathol 138:119–128PubMedGoogle Scholar
  26. Odom DG, Donatucci CF, Deshon GE (1990) Mucinous adenocarcinoma of the prostate. Hum Pathol 21:593–600CrossRefGoogle Scholar
  27. Oesterling JE, Brendler CB, Epstein JI, Kimball AW Jr, Walsh PC (1987) Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate. J Urol 138:92–98PubMedGoogle Scholar
  28. Perlman E, Epstein JI (1990) Blood group antigen expression in dysplasia and adenocarcinoma of the prostate. Am J Surg Pathol 14:810–818PubMedCrossRefGoogle Scholar
  29. Quinn BD, Cho KR, Epstein JI (1990) Relationship of severe dysplasia to stage B adenocarcinoma of the prostate. Cancer 65:2321–2327PubMedCrossRefGoogle Scholar
  30. Reese JH, McNeal JE, Redwine EA, Samloff IM, Stamey TA (1986) Differential distribution of pepsinogen II between the zones of the human prostate and the seminal vesicle. J Urol 136:1148PubMedGoogle Scholar
  31. Reese JH, McNeal JE, Redwine EA, Stamey TA, Freiha FS (1988) Tissue type plasminogen activator as a marker for functional zones, within the human prostate gland. Prostate 12:47PubMedCrossRefGoogle Scholar
  32. Villers AA, McNeal JE, Freiha FS, Stamey TA (1991) Development of prostatic carcinoma: morphometric and pathological features of early stages. Acta Oncol 30:145–149PubMedCrossRefGoogle Scholar
  33. Walker AN, Mills SE, Fechner RE, Perry JM (1982) “Endometrial” adenocarcinoma of the prostatic urethra arising in a villous polyp: a light microscopic and immunoperoxidase study. Arch Pathol Lab Med 106:624–627PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • R. S. Kirby

There are no affiliations available

Personalised recommendations